News roundup from Datamonitor
September 26, 2007Sales and Marketing
Alnylam and Merck end collaborationBiopharmaceutical company Alnylam Pharmaceuticals and Merck & Co. have mutually agreed to terminate their July 2006 …
UK clinical trials: on the mend?
September 26, 2007Research and Development UK, clinical trials, global, research
How clinical research is organised in the UK is essential to the success of Britain's pharma industry, and to the …
Global products for local people: tailoring your brand strategy
September 25, 2007Medical Communications, Sales and Marketing branding, global
Deciding which aspects of a global brand should be defined centrally and how much freedom there is in any given …
European approval for GSK’s cancer vaccine
September 25, 2007Sales and Marketing
GlaxoSmithKline's cervical cancer vaccine Cervarix has been approved in Europe, setting it up for a head-to-head clash with Sanofi-Pasteur MSD's …
Pfizer’s Celsentri approved in Europe
September 25, 2007Research and Development, Sales and Marketing HIV
Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …
Brown outlines plans for NHS in a ‘new era’
September 25, 2007The Prime Minister has outlined his plans to provide NHS patients with a more personalised service fit for the 21st …
AstraZeneca denies outsourcing plans
September 25, 2007Manufacturing and Production
AstraZeneca has denied it plans to outsource its drug manufacturing requirements by 2017, following comments made by a senior board …
Takeda claims safety advantages for Actos
September 20, 2007Sales and Marketing
Takeda says new data on its diabetes drug Actos shows a number of safety advantages over GSK's rival product Avandia.Two …
Clinton unveils plans for universal healthcare
September 19, 2007Sales and Marketing
Hilary Clinton has unveiled plans to introduce universal healthcare insurance in America as part of her campaign to become US …
Latest news from Datamonitor
September 17, 2007Research and Development, Sales and Marketing
Cell Therapeutics launches Phase III study for pixantroneCell Therapeutics has launched its phase III clinical trial, known as PIX303, of …
NICE approves MSD and Schering-Plough’s Ezetrol
September 14, 2007Sales and Marketing Inegy, NICE, cv
NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …
Novartis launches Cubicin for MRSA
September 14, 2007Sales and Marketing
Novartis has launched Cubicin – its novel, first-in-class antibiotic – in the UK, in a new indication to treat the …
AstraZeneca looks to outflank cholesterol competitors
September 14, 2007Sales and Marketing
AstraZeneca is to conduct a head-to-head trial of Crestor against rival treatment Vytorin in the hugely competitive cholesterol treatment market.The …
BMS outsources safety monitoring to India
September 14, 2007Sales and Marketing India, safety
A team of 140 people based in Chennai, India, is to help Bristol-Myers Squibb monitor safety and side-effect reports from …
Fleishman-Hillard to assist UCB in its Cimzia launch
September 14, 2007Medical Communications
UCB is preparing its Crohn's disease treatment, Cimzia, for a 2008 launch in Europe.This is the first of a number …
Pfizer closes Kent manufacturing base
September 14, 2007Manufacturing and Production
Pfizer will close its Sandwich, Kent manufacturing plant over the next two years with the loss of 420 jobs.It spells …
Resolute wins first global account
September 12, 2007Medical Communications Resolute
London-based PR agency Resolute has won its first global account since setting up its New York office earlier this year.The …
Boehringer bids for oncology presence with lung cancer treatment
September 10, 2007Sales and Marketing
A novel treatment for lung cancer which could help patients who develop resistance to other drugs is being developed by …
UK stem-cell research to benefit from hybrid embryos decision
September 10, 2007Research and Development stem cell
A new ruling on the use of hybrid human-animal embryos could help UK researchers extend their lead over European rivals.The …
How can customer insight work for you?
September 10, 2007Sales and Marketing customers, insight, sales
It should be a very simple equation: if you can understand what motivates clinicians – and all the other prescribing …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
